Photothermally Triggered Copper Payload Release for Cuproptosis-Promoted Cancer Synergistic Therapy

Angew Chem Int Ed Engl. 2023 Mar 13;62(12):e202213922. doi: 10.1002/anie.202213922. Epub 2023 Feb 10.

Abstract

Cuproptosis is a new form of programmed cell death and exhibits enormous potential in cancer treatment. However, reducing the undesirable Cu ion release in normal tissue and maximizing the copper-induced therapeutic effect in cancer sites are two main challenges. In this study, we constructed a photothermally triggered nanoplatform (Au@MSN-Cu/PEG/DSF) to realize on-demand delivery for synergistic therapy. The released disulfiram (DSF) chelated with Cu2+ in situ to generate highly cytotoxic bis(diethyldithiocarbamate)copper (CuET), causing cell apoptosis, and the formed Cu+ species promoted toxic mitochondrial protein aggregation, leading to cell cuproptosis. Synergistic with photothermal therapy, Au@MSN-Cu/PEG/DSF could effectively kill tumor cells and inhibit tumor growth (inhibition rate up to 80.1 %). These results provide a promising perspective for potential cancer treatment based on cuproptosis, and may also inspire the design of advanced nano-therapeutic platforms.

Keywords: Copper Delivery; Cuproptosis; Nanostructures; Photothermally Triggered Release; Synergistic Therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Apoptosis*
  • Cell Line, Tumor
  • Copper / pharmacology
  • Disulfiram / pharmacology
  • Disulfiram / therapeutic use
  • Ditiocarb
  • Humans
  • Neoplasms* / drug therapy

Substances

  • Antineoplastic Agents
  • Copper
  • Disulfiram
  • Ditiocarb